We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.54B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+22.19%
3 Year Est. Return
+76.82%
5 Year Est. Return
+87.33%
10 Year Est. Return
+300.59%
AUM
$2.48B
AUM Growth
-$34.4M
Cap. Flow
-$68.7M
Cap. Flow %
-2.77%
Top 10 Hldgs %
37.3%
Holding
187
New
3
Increased
37
Reduced
75
Closed
7

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.23M
2
LLY icon
Eli Lilly
LLY
+$431K
3
ABT icon
Abbott
ABT
+$312K
4
EXEL icon
Exelixis
EXEL
+$227K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$226K

Sector Composition

Rank Sector Weight
1 Technology 26.97%
2 Financials 13.87%
3 Healthcare 11.95%
4 Communication Services 10.39%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLU icon
176
State Street Utilities Select Sector SPDR ETF
XLU
$23.5B
$208K 0.01%
5,502
-312
-5% -$12.4K
COIN icon
177
Coinbase
COIN
$42.3B
$208K 0.01%
+837
New +$212K
EPD icon
178
Enterprise Products Partners
EPD
$82.2B
$203K 0.01%
+6,468
New +$199K
CEG icon
179
Constellation Energy
CEG
$89.9B
$201K 0.01%
899
NOTE
180
DELISTED
FiscalNote
NOTE
$128K 0.01%
9,994
BAX icon
181
Baxter International
BAX
$12.1B
-6,490
Closed -$246K
CDW icon
182
CDW
CDW
$17.2B
-1,126
Closed -$255K
CTAS icon
183
Cintas
CTAS
$82.5B
-1,492
Closed -$307K
FTLS icon
184
First Trust Long/Short Equity ETF
FTLS
$2.45B
-32,215
Closed -$2.04M
IBB icon
185
iShares Biotechnology ETF
IBB
$9.23B
-1,492
Closed -$217K
RWR icon
186
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
-2,015
Closed -$215K
UL icon
187
Unilever
UL
$135B
-2,956
Closed -$216K

Similar funds

Klingenstein Fields & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Klingenstein Fields & Co held 187 positions worth $2.48B, down 1.4% from $2.52B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q4 2024 filing shows 3 new, 37 increased, 75 reduced and 7 closed positions. Its largest new stake was Exelixis: 7,000 shares worth $233K. The largest sale was Schwab International Equity ETF, an estimated $15.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Klingenstein Fields & Co's largest Q4 2024 buy was Exelixis: 7,000 shares worth $233K.
  • Klingenstein Fields & Co added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $5.23M increase.
  • Klingenstein Fields & Co's biggest Q4 2024 reduction was Schwab International Equity ETF, cutting an estimated $15.5M.
  • Klingenstein Fields & Co fully exited First Trust Long/Short Equity ETF in Q4 2024, selling an estimated $2.04M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.48B portfolio in Q4 2024.
  • Klingenstein Fields & Co opened 3 new positions and closed 7 in Q4 2024.
  • Klingenstein Fields & Co's portfolio value fell 1.4% quarter-over-quarter to $2.48B.

Based on Klingenstein Fields & Co's 13F filing for Q4 2024, filed 30 Jan 2025.